Navigation Links
San Diego universities, government and industry rally around local Clean-Tech cluster
Date:11/6/2008

will serve as the key component of a technology for transforming a broad-spectral width solar beam into optical energy that can be massively transported via optical fibers to user locations. The solar spectral concentrator can potentially advance the current generation of solar energy collection. Today's photovoltaic (PV) systems are often based upon directly converting solar energy directly into electrical energy. Yu's technology, in contrast, would enable efficient transport and distribution of energy in optical form before final conversion and usage. This will allow for flexible yet direct use of solar energy, and will take advantage of any advances in PV systems. Once established as an alternate way to power up the utilities using solar energy, this proposed technology could be employed broadly world wide.

Yu Qiao, Structural Engineering professor, UC San Diego Jacobs School of Engineering
Developing Ultrahigh-Efficiency Thermal-Energy Harvesting Materials: In this proposed project Qiao and his team are developing unique ways to convert waste heat to electricity by using a nanoporous system. A nanoporous material is a solid that contains nanometer sized pores. This technique re-investigates a mechanism that has long been over-looked and uses it to convert wasted heat to electricity with high efficiency and high power density. The specific goals of this project are to perform comprehensive characterization experiments on nanoporous systems under various conditions; to develop a prototype that can harvest useful electricity from ambient temperature; and to develop a presentation and demonstration set for potential partners, investors, customers, and/or licensees.

John J. Love, Professor, Department of Chemistry and Biochemistry, San Diego State University
Bio-diesel from Cell Membranes: Utilizing Protein Design to Re-Engineer Natural Enzymes for the Extraction of Biodiesel from Cell Membranes: The goal of this project i
'/>"/>

Contact: Andrea Siedsma
asiedsma@soe.ucsd.edu
858-822-0899
University of California - San Diego
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Genetic clock makers at UC San Diego publish their timepiece in Nature
2. Gable PR Honored by PRSA San Diego Chapter with Three Awards for Client Programs
3. DermTech and Rady Childrens Hospital-San Diego, Initiate Study to Understand Effects of Vitamin D as a Treatment for Atopic Dermatitis in Children and Young Adults
4. Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
5. Amicus Therapeutics Opens Research Facility in San Diego
6. San Diegos Original Biotech Company Celebrates 30th Anniversary With Reunion
7. Glowing films developed by UC San Diego chemists reveal traces of explosives
8. HDSA-San Diegos Team 2CureHD Continues its Race to Cure Huntingtons Disease
9. UC San Diego nanostructures will raise thin-film solar cell efficiency
10. Nanowires may boost solar cell efficiency, UC San Diego engineers say
11. ABR-Affinity BioReagents to Participate in the American Association for Cancer Research Meeting in San Diego, California, April 12 - 16, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 2Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Cell Biosciences Acquires Protein Forest 2Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2